[Award Report] FY2022 Takemi Memorial Award for Research in Seizon and Life Sciences (The Takemi Memorial Award for Research in Seizon and Life Sciences, December 2022)
date : 3/3/2023
Tags: Other activities
![[Award Report] FY2022 Takemi Memorial Award for Research in Seizon and Life Sciences (The Takemi Memorial Award for Research in Seizon and Life Sciences, December 2022)](https://hgpi.org/en/wp-content/uploads/sites/2/lecture-media-213-top.png)
Health and Global Policy Institute (HGPI) Board Member and CEO Mr. Ryoji Noritake has been awarded the FY2022 Takemi Memorial Award for Research in Seizon and Life Sciences. Mr. Noritake was recognized for his contributions to the development of a mature civil society by creating opportunities for diverse stakeholders in society and the parties most affected in various areas to come together for exchanges of opinion that surpass the positions of individuals. At Mr. Noritake’s request, the monetary prize from the award has been donated to HGPI.
■ Introducing the Takemi Memorial Award for Research in Seizon and Life Sciences
The Takemi Memorial Award for Research in Seizon and Life Sciences recognizes individuals or groups who will serve as future leaders of Japan and have made noteworthy achievements through innovative research and practical activities in basic, clinical, and social medicine in life sciences or related fields. (From the website of the Takemi Memorial Award for Research in Seizon and Life Sciences.)
For further details, please refer to the website of the Takemi Memorial Award for Research in Seizon and Life Sciences.
Top Research & Recommendations Posts
- [Publication Report] Planetary Health Promotion Project “Issues Facing Planetary Health and the Role of the Health Sector” (May 10, 2023)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Policy Recommendations] Building a Research and Development System Together With People Living with Dementia and Their Families to Drive Parallel Progress in Creating an Inclusive Society and Advancing R&D (April 25, 2023)
- [Public Comment Submission] Opinions Regarding the Proposed “National Action Plan on Antimicrobial Resistance 2023-2027 (Draft)” (March 16, 2023)
- [Recommendations] Recommendations for the G7 Hiroshima Summit in 2023 Necessary Actions for AMR Control, Starting with the Introduction of Pull Incentives (August 29, 2022)
- [Policy Recommendations] Recommendations for the G7 Hiroshima Summit by the C7 Global Health Working Group (April 20, 2023)
- [Policy Recommendations] Requests for the G7 Hiroshima Summit and Related Ministerial Meetings: Promoting Measures for Climate Change and Planetary Health That Keep Pace With the International Community (December 19, 2022)
- [Research Report] The Public Opinion Survey on Mental Health (August 12, 2022)
- [Recommendations] Restructuring Diagnostic Services and Achieving the Necessary Innovation to Promote AMR Control (May 26, 2023)
Featured Posts
-
2023-05-12
[Event Report] Recommendations to Prime Minister Fumio Kishida on the issue of antimicrobial resistance (AMR) in the G7 Hiroshima Summit Leaders’ Declaration (April 28, 2023)
-
2023-05-15
[Event Report] (Live Broadcasting) A Dementia Symposium Commemorating the G7 Health Ministers’ Meeting in Nagasaki “Collaboration in the International Community for Advancing Dementia Measures in a New Era” (May 14, 2023)
-
2023-05-18
[Event Report] A NAGASAKI Planetary Health Expert Meeting “From COP27 and COP15 to the G7 Hiroshima Summit: New Partnerships for Solving Climate, Environment, Biodiversity and Health Issues” (May 12, 2023)
-
2023-05-19
[RegistrationOpen] Health Policy Academy the 12th Session
-
2023-05-26
[Recommendations] Restructuring Diagnostic Services and Achieving the Necessary Innovation to Promote AMR Control (May 26, 2023)